# Air Pollution, Epigenetics and Cardiovascular Health: A Human Intervention Trial

> **NCT01864824** · PHASE1 · COMPLETED · sponsor: **Harvard School of Public Health (HSPH)** · enrollment: 10 (actual)

## Conditions studied

- Heart Rate
- Heart Rate Variability
- Inflammation

## Interventions

- **DRUG:** methyl donor
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01864824
- **Lead sponsor:** Harvard School of Public Health (HSPH)
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2017-05-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01864824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01864824, "Air Pollution, Epigenetics and Cardiovascular Health: A Human Intervention Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01864824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*